Trial Outcomes & Findings for Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD) (NCT NCT01259596)

NCT ID: NCT01259596

Last Updated: 2018-08-29

Results Overview

self-reported severity and frequency of worry the scores range from 8 to 40, with higher scores representing higher severity of worry. Higher scores represent worse outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

141 participants

Primary outcome timeframe

baseline to week 13

Results posted on

2018-08-29

Participant Flow

Participant milestones

Participant milestones
Measure
Cognitive-behavioral Therapy
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Overall Study
STARTED
70
71
Overall Study
COMPLETED
66
65
Overall Study
NOT COMPLETED
4
6

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cognitive-behavioral Therapy
n=70 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=71 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Total
n=141 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
41 Participants
n=5 Participants
34 Participants
n=7 Participants
75 Participants
n=5 Participants
Age, Categorical
>=65 years
29 Participants
n=5 Participants
37 Participants
n=7 Participants
66 Participants
n=5 Participants
Sex: Female, Male
Female
58 Participants
n=5 Participants
57 Participants
n=7 Participants
115 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
14 Participants
n=7 Participants
26 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
70 Participants
n=5 Participants
71 Participants
n=7 Participants
141 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
4 Participants
n=5 Participants
2 Participants
n=7 Participants
6 Participants
n=5 Participants
Race (NIH/OMB)
White
64 Participants
n=5 Participants
64 Participants
n=7 Participants
128 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
5 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
70 participants
n=5 Participants
71 participants
n=7 Participants
141 participants
n=5 Participants

PRIMARY outcome

Timeframe: baseline to week 13

self-reported severity and frequency of worry the scores range from 8 to 40, with higher scores representing higher severity of worry. Higher scores represent worse outcome.

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Changes From Baseline in Penn State Worry Questionnaire (PSWQ-A) at Week 13
-9.44 units on a scale
Interval -11.02 to -7.86
-5.37 units on a scale
Interval -6.89 to -3.85

PRIMARY outcome

Timeframe: baseline to week 13

interviewer-rated severity of anxiety symptoms; the scores range from 0 to 56, with higher scores representing higher severity of anxiety. Higher scores represent worse outcome.

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=64 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Changes From Baseline in Hamilton Anxiety Rating Scale (HAM-A) at Week 13
-7.04 units on a scale
Interval -8.88 to -5.21
-5.53 units on a scale
Interval -7.28 to -3.77

SECONDARY outcome

Timeframe: baseline to week 13

self report measure of depressive symptoms; scores range from 0 to 63, with a higher score representing higher levels of depressive symptoms Higher scores represent worse outcome.

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=64 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Changes From Baseline in Beck Depression Inventory (BDI) at 13 Weeks
-10.77 units on a scale
Interval -12.73 to -8.81
-7.54 units on a scale
Interval -9.44 to -5.64

SECONDARY outcome

Timeframe: week 13

self report measure of perceived difficulties with mobility and performing basic and advanced activities of daily living; the scale consists of 19 items; scores range from 19 to 114, with higher scores indicating more disability. Higher scores represent worse outcome.

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Pepper Center Tool for Disability (PCT-D)
1.71 units on a scale
Interval 1.55 to 1.87
1.86 units on a scale
Interval 1.7 to 2.01

SECONDARY outcome

Timeframe: week 13

physical and emotional health related quality of life; The SF-36 is a self-report measure of health-related quality of life (HRQL) consisting of 36 items that form 8 subscales: physical functioning, role limitations due to physical health problems, role limitations due to emotional health problems, social functioning, freedom from pain, energy, emotional well-being, and general health perceptions. These 8 subscales are also combined into two domains: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). All of these scales range from 0 (maximum impairment) to 100 (no impairment). A lower score represents worse outcome.

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Short Form (36) Health Survey (SF-36) to Week 13
60.5 units on a scale
Interval 55.9 to 65.1
53.5 units on a scale
Interval 49.1 to 57.9

SECONDARY outcome

Timeframe: week 13

self-report symptoms of insomnia; scores range from 0 to 28 with higher scores indicating greater symptoms of sleep disturbance; higher score represents worse outcomes

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Insomnia Severity Index (ISI)
8.70 units on a scale
Interval 7.1 to 10.3
11.9 units on a scale
Interval 10.4 to 13.4

SECONDARY outcome

Timeframe: baseline to week 13

Diagnostic and Statistical Manual of Mental Disorders, IV edition (DSM-IV0) symptoms of Generalized Anxiety Disorder; scores range from 0 to 24 with higher scores indicating greater symptoms of GAD; higher score represents worse outcome

Outcome measures

Outcome measures
Measure
Cognitive-behavioral Therapy
n=65 Participants
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=64 Participants
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Changes From Baseline in Generalized Anxiety Disorder-7 (GAD-7) to Week 13
-5.63 units on a scale
Interval -6.82 to -4.44
-3.27 units on a scale
Interval -4.4 to -2.14

Adverse Events

Cognitive-behavioral Therapy

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Nondirective Supportive Therapy

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Cognitive-behavioral Therapy
n=70 participants at risk
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=71 participants at risk
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Psychiatric disorders
serious adverse event
0.00%
0/70
0.00%
0/71

Other adverse events

Other adverse events
Measure
Cognitive-behavioral Therapy
n=70 participants at risk
Cognitive-behavioral therapy consists of psychoeducation, relaxation techniques, cognitive therapy, problem-solving, thought stopping, behavioral activation, exposure, coping with pain, sleep, and relapse prevention psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Nondirective Supportive Therapy
n=71 participants at risk
Nondirective supportive therapy consists of providing a warm and accepting environment in which a person can reflect on their experiences, thoughts, and feelings psychotherapy: weekly individual psychotherapy by telephone for 12 weeks; 4 booster sessions
Psychiatric disorders
adverse event
5.7%
4/70 • Number of events 4
5.6%
4/71 • Number of events 4

Additional Information

Gretchen A. Brenes, Ph.D.

Wake Forest School of Medicine

Phone: 336-716-4551

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place